Purchase Order HHSN272201701026P

This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for the delivery of a cell dissociator and cell separator. The award, valued at $58,517.50, was made without a set-aside designation and has an ultimate completion date of September 30, 2017.

Miltenyi Biotec is a well-established federal contractor, providing specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development for numerous government agencies, including the NIH, Department of Veterans Affairs, Food and Drug Administration, Department of Defense, and Centers for Disease Control and Prevention. This purchase order is likely part of the company's broader portfolio of contracts supporting the NIH's clinical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Of note, Miltenyi Biotec currently holds a $2.3 million indefinite delivery contract with the NIH Clinical Center to supply proprietary CliniMACS reagents and consumables for cell therapy manufacturing used in NIH clinical trials.